Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paari Murugan

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Advanced Materials Technologies|April 3, 2018
3D Printed Organ Models with Physical Properties of Tissue and Integrated SensorsKaiyan Qiu, Zichen Zhao, Ghazaleh Haghiashtiani, et al.
Molecular Cancer Research : MCR|March 2, 2021
Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene FusionsJong Hyuk Kim, Kate Megquier, Rachael Thomas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapyRajesh R Singh, Paari Murugan, Lalit R Patel, et al.
European Urology Oncology|November 5, 2025
Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade SamplesRoberto Ruiz-Cordero, Qi Wang, Gayatri Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial CarcinomaFrançois Audenet, Sumit Isharwal, Eugene K Cha, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Cell Reports. Medicine|June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cellsAlexander K Tsai, John R Lozada, Philippa R Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2025
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancerSamuel P Pitzen, Amber N Rudenick, Yinjie Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Molecular Characterization of Neuroendocrine-like Bladder CancerJosé Batista da Costa, Ewan A Gibb, Trinity J Bivalacqua, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Advanced Materials Technologies|April 3, 2018
3D Printed Organ Models with Physical Properties of Tissue and Integrated SensorsKaiyan Qiu, Zichen Zhao, Ghazaleh Haghiashtiani, et al.
Molecular Cancer Research : MCR|March 2, 2021
Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene FusionsJong Hyuk Kim, Kate Megquier, Rachael Thomas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapyRajesh R Singh, Paari Murugan, Lalit R Patel, et al.
European Urology Oncology|November 5, 2025
Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade SamplesRoberto Ruiz-Cordero, Qi Wang, Gayatri Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2018
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial CarcinomaFrançois Audenet, Sumit Isharwal, Eugene K Cha, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Cell Reports. Medicine|June 26, 2026
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cellsAlexander K Tsai, John R Lozada, Philippa R Kennedy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2025
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancerSamuel P Pitzen, Amber N Rudenick, Yinjie Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Molecular Characterization of Neuroendocrine-like Bladder CancerJosé Batista da Costa, Ewan A Gibb, Trinity J Bivalacqua, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Pageof 9